Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 1998, p. 2294-2297, Vol. 36, No. 8
Hospital Infections
Program1 and
Division of Bacterial and
Mycotic Diseases,2 National Center for
Infectious Diseases,
Received 9 February 1998/Returned for modification 16 March
1998/Accepted 12 May 1998
The VanC phenotype, as found in Enterococcus
gallinarum, E. casseliflavus, and E. flavescens, is characterized by intrinsic low-level resistance to
vancomycin. The nucleotide sequences of the vanC-1 gene in
E. gallinarum, the vanC-2 gene in
E. casseliflavus, and the vanC-3 gene in
E. flavescens have been reported, although there is
some disagreement as to whether E. flavescens is a
legitimate enterococcal species. Previous attempts to
differentiate the vanC-2 and vanC-3 genes by
PCR analysis have been unsuccessful. The purpose of the present study
was to detect and differentiate the three vanC determinants
and examine the distribution of these genes in a collection of both
typical and atypical enterococci. The 796-bp vanC-1 PCR
product was amplified only from E. gallinarum isolates. As expected, due to the extensive homology in the
vanC-2 and vanC-3 gene sequences, all of
the E. casseliflavus and E. casseliflavus/flavescens isolates produced the 484-bp
vanC-2 PCR product, although the E. gallinarum isolates were negative. Only the E. casseliflavus/flavescens isolates produced the 224-bp
vanC-3 product. Using the three sets of primers, we were
able to detect and distinguish the vanC-1,
vanC-2, and vanC-3 genes from both typical and
atypical enterococci strains. Antimicrobial susceptibility tests and
analysis of genomic DNA by pulsed-field gel electrophoresis were also
performed, but the results indicated that they were not able to
distinguish among strains possessing the three vanC genotypes.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Detection and Differentiation of vanC-1,
vanC-2, and vanC-3 Glycopeptide Resistance Genes
in Enterococci
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, 1600 Clifton Rd. NE, Mailstop G-08,
Atlanta, GA 30333. Phone: (404) 639-0195. Fax: (404) 639-1381. E-mail: ncc1{at}cdc.gov.
Journal of Clinical Microbiology, August 1998, p. 2294-2297, Vol. 36, No. 8
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»